This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations.
Er den nåværende prisen et godt tilbud?
Grafen over prisutviklingen viser den laveste prisen over tid, eksklusiv fraktkostnader.
17 feb. 2025
17 feb. 2025